Pyxis Oncology, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Civik Thomas | — | Purchase | 15,700 | $12.74 | $200,018 | 15,700 | Nov 18, 2021 |
| Chin Mark | — | C | 1,433,261 | — | — | 1,433,261 | Oct 13, 2021 |
| FLAVIN JOHN L | — | C | 2,388 | — | — | 171,610 | Oct 13, 2021 |
| Bayer World Investments B.V. | — | C | 2,742,338 | — | — | 2,742,338 | Oct 13, 2021 |
| Cormorant Asset Management, LP | — | C | 668,854 | — | — | 668,854 | Oct 13, 2021 |
| Feingold Jay | Chief Medical Officer | Award / Grant | 43,750 | — | — | 43,750 | Oct 7, 2021 |